178 related articles for article (PubMed ID: 19466271)
1. Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis.
Faria EJ; Faria IC; Ribeiro JD; Ribeiro AF; Hessel G; Bertuzzo CS
J Bras Pneumol; 2009 Apr; 35(4):334-42. PubMed ID: 19466271
[TBL] [Abstract][Full Text] [Related]
2. Association of TGF-beta1, CD14, IL-4, IL-4R and ADAM33 gene polymorphisms with asthma severity in children and adolescents.
de Faria IC; de Faria EJ; Toro AA; Ribeiro JD; Bertuzzo CS
J Pediatr (Rio J); 2008; 84(3):203-10. PubMed ID: 18425216
[TBL] [Abstract][Full Text] [Related]
3. Influence of SNPs in Genes that Modulate Lung Disease Severity in a Group of Mexican Patients with Cystic Fibrosis.
Yokoyama E; Chávez-Saldaña M; Orozco L; Cuevas F; Lezana JL; Vigueras-Villaseñor RM; Rojas-Castañeda JC; Landero DA
Arch Med Res; 2018 Jan; 49(1):18-26. PubMed ID: 29703608
[TBL] [Abstract][Full Text] [Related]
4. Complex two-gene modulation of lung disease severity in children with cystic fibrosis.
Dorfman R; Sandford A; Taylor C; Huang B; Frangolias D; Wang Y; Sang R; Pereira L; Sun L; Berthiaume Y; Tsui LC; Paré PD; Durie P; Corey M; Zielenski J
J Clin Invest; 2008 Mar; 118(3):1040-9. PubMed ID: 18292811
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers of lung disease in cystic fibrosis.
Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of TGF-beta1 in cystic fibrosis patients.
Brazova J; Sismova K; Vavrova V; Bartosova J; Macek M; Lauschman H; Sediva A
Clin Immunol; 2006 Dec; 121(3):350-7. PubMed ID: 17052957
[TBL] [Abstract][Full Text] [Related]
7. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
[TBL] [Abstract][Full Text] [Related]
8. Correlation between MBL2/CD14/TNF-α gene polymorphisms and susceptibility to spinal tuberculosis in Chinese population.
Zheng M; Shi S; Wei W; Zheng Q; Wang Y; Ying X; Lu D
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29298876
[TBL] [Abstract][Full Text] [Related]
9. Mannose-binding lectin gene as a modifier of the cystic fibrosis phenotype in Argentinean pediatric patients.
Gravina LP; Crespo C; Giugno H; Sen L; Chertkoff L; Mangano A; Castaños C
J Cyst Fibros; 2015 Jan; 14(1):78-83. PubMed ID: 25178872
[TBL] [Abstract][Full Text] [Related]
10. The effect of TGF-β
Trojan T; Alejandre Alcazar MA; Fink G; Thomassen JC; Maessenhausen MV; Rietschel E; Schneider PM; van Koningsbruggen-Rietschel S
BMC Pulm Med; 2022 May; 22(1):183. PubMed ID: 35525938
[TBL] [Abstract][Full Text] [Related]
11. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease.
Chou HT; Chen CH; Tsai CH; Tsai FJ
Am Heart J; 2004 Jul; 148(1):181-6. PubMed ID: 15215809
[TBL] [Abstract][Full Text] [Related]
12. Study of the effect of DNA polymorphisms in the mannose-binding lectin gene (MBL2) on disease severity in Slovak cystic fibrosis patients.
Tarova ET; Polakova H; Kayserova H; Celec P; Zuzulova M; Kadasi L
Gen Physiol Biophys; 2011 Dec; 30(4):373-8. PubMed ID: 22131319
[TBL] [Abstract][Full Text] [Related]
13. IL1B polymorphisms modulate cystic fibrosis lung disease.
Levy H; Murphy A; Zou F; Gerard C; Klanderman B; Schuemann B; Lazarus R; García KC; Celedón JC; Drumm M; Dahmer M; Quasney M; Schneck K; Reske M; Knowles MR; Pier GB; Lange C; Weiss ST
Pediatr Pulmonol; 2009 Jun; 44(6):580-93. PubMed ID: 19431193
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
15. Gene modifiers in cystic fibrosis.
Accurso FJ; Sontag MK
J Clin Invest; 2008 Mar; 118(3):839-41. PubMed ID: 18292812
[TBL] [Abstract][Full Text] [Related]
16. Update on gene modifiers in cystic fibrosis.
Collaco JM; Cutting GR
Curr Opin Pulm Med; 2008 Nov; 14(6):559-66. PubMed ID: 18812833
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.
Sagwal S; Chauhan A; Kaur J; Prasad R; Singh M; Singh M
Lung; 2020 Apr; 198(2):377-383. PubMed ID: 31919585
[TBL] [Abstract][Full Text] [Related]
18. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
19. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
Bremer LA; Blackman SM; Vanscoy LL; McDougal KE; Bowers A; Naughton KM; Cutler DJ; Cutting GR
Hum Mol Genet; 2008 Jul; 17(14):2228-37. PubMed ID: 18424453
[TBL] [Abstract][Full Text] [Related]
20. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.
Collaco JM; Vanscoy L; Bremer L; McDougal K; Blackman SM; Bowers A; Naughton K; Jennings J; Ellen J; Cutting GR
JAMA; 2008 Jan; 299(4):417-24. PubMed ID: 18230779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
